Omnia SanaPlant Comparison
Arnica vs Chaga
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Arnica and Chaga: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Arnica | Chaga | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 7/10 | 1/10 | Stronger for Arnica |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Infection (general) | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 7/10 | 1/10 | Stronger for Arnica |
| Skin irritation | 7/10 | 1/10 | Stronger for Arnica |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The main anti-inflammatory principles; also responsible for the plant's toxicity and contact-allergy potential.
Aromatic and supporting constituents of the flower.
Present in small amounts; relevant to the caution against internal use.
Chaga's dark colour comes from melanin-like pigments; it also concentrates betulinic-acid-type triterpenes absorbed from its birch host, associated with antioxidant and anticancer research interest.
Immunomodulatory polysaccharides contributing to the traditional tonic and immune-support use.
Antioxidant phenolics contributing to chaga's free-radical-scavenging activity.
Pharmacological Actions
Topical anti-inflammatory for bruising, swelling and sprains
Helenalin, the sesquiterpene lactone of Arnica montana, shows anticancer activity against multiple tumour types in vitro and in vivo, largely by covalently inhibiting NF-kappaB p65 and inducing apoptosis (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Antiecchymotic / vulnerary (helps disperse bruises); Topical anti-inflammatory for bruising, swelling and sprains
Arnica montana and its constituent helenalin exert anticancer activity against several tumour types in vitro and in vivo, inhibiting NF-kappaB (p65) signalling, inducing apoptosis and synergizing with other anticancer agents (preclinical).
inferred from antimicrobial action
inferred from anti-inflammatory action
Topical analgesic for muscle soreness and pain
Topical analgesic for muscle soreness and pain
inferred from anti-inflammatory action
Topical anti-inflammatory for bruising, swelling and sprains
inferred from anti-inflammatory action
inferred from anticancer action
inferred from immunomodulator action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Chaga-derived 3,4-DHBA protected against Parkinson's-related neurotoxicity (preclinical).
Chaga polysaccharide lowered lipids in vivo and in vitro.
Safety, Cautions & Contraindications
EXTERNAL USE ONLY on unbroken skin. Arnica is toxic if swallowed and can cause stomach pain, vomiting, diarrhoea, breathing difficulty, irregular heartbeat and, in serious cases, cardiac arrest; the only safe oral form is the highly diluted homeopathic preparation.
Do not apply to broken or damaged skin, open wounds, eyes or mucous membranes.
As a member of the daisy family (Asteraceae) it can cause allergic contact dermatitis; prolonged topical use can also irritate the skin.
Autoimmune conditions: Chaga can stimulate parts of the immune system—people with autoimmune diseases should be cautious.Blood thinners: Chaga contains compounds that may affect clotting—avoid large doses if on anticoagulants.Blood sugar meds: May slightly lower glucose—monitor if taking diabetes medication.Pregnancy & breastfeeding: Limited safety data—best avoided unless guided by a professional.Quality matters: Wild-harvested Chaga can accumulate heavy metals from trees and soil—source from reputable suppliers.
External Ids
Botanical Description
Aromatic mountain perennial herb with a basal rosette of oval, hairy leaves and one or two pairs of smaller opposite leaves on an erect, softly hairy flowering stem. Each stem bears one or a few large, bright golden-yellow, daisy-like flower heads with narrow, slightly twisted ray florets.[4]
Parasitic wood-decay fungus (not a true plant) that grows almost entirely inside the trunk of living birch trees, visible externally only as a hard, black, cracked, charcoal-like mass (a sclerotium, sometimes called a 'conk') erupting through the bark. Unlike typical mushrooms, chaga has no true cap, gills or stem; its fertile spore-producing surface develops later, hidden beneath the bark after the tree dies.[1]
Habitat
Grows in acidic, nutrient-poor mountain meadows, pastures and open woodland, typically at moderate to high elevations across central and northern Europe; increasingly scarce in the wild due to habitat loss and overharvesting.[4]
Grows almost exclusively as a parasite on living birch trees in cold, northern temperate and boreal forests of Europe, Russia, North America and Asia.[1]
Harvesting
The flower heads are picked by hand as they open, in mid- to late summer, and dried quickly in a warm, shaded, airy place; wild populations are protected in many regions, so cultivated or sustainably wildcrafted material is preferred.[4]
The hard black external mass (conk) is chopped or broken away from the living birch trunk, ideally without killing the tree, then dried and broken into pieces or ground for use; sustainable harvesting (leaving part of the conk to regrow) is recommended given the fungus's slow growth.
Traditional Uses
Arnica flower has a long central European folk reputation, reflected in the name 'leopard's bane' and 'mountain tobacco', as a topical remedy for bruising, sprains, muscle soreness and swelling after minor injury, applied only to unbroken skin. Internal use of the whole herb has always been considered dangerous and is confined to highly diluted homeopathic preparations.[4]
Chaga has a long traditional use in Russian, Siberian, Baltic and Scandinavian folk medicine as a tonic remedy for digestive complaints, immune support and general vitality, traditionally taken as a dark, tea-like decoction; this traditional tonic reputation is now studied for its antioxidant, immunomodulatory and anti-inflammatory properties.[1, 4]
Preparations
Standardised flower extract formulated into a cream, gel or ointment for external application to bruises, sprains and muscle soreness on unbroken skin.
Alcoholic tincture of the dried flower heads, diluted before topical application as a compress; never taken internally in this form.
Dosage
The EU herbal monograph gives cutaneous use only, in adolescents, adults and elderly - a semi-solid preparation containing 20-25% tincture applied as a thin layer 2-3 times daily, a 50% liquid-extract preparation 2-4 times daily, or 2.5 mL of a liquid preparation as an impregnated dressing 3-4 times daily. Apply to unbroken skin only. If symptoms persist after 3 to 4 days a healthcare practitioner should be consulted. Not recommended under 12 years. Never taken by mouth except as a highly diluted homeopathic preparation. Educational reference only, not a prescription.
Not documented
References
Lookalikes Review
References & Sources
- Toma, C.C., Marrelli, M., Puticiu, M., Conforti, F. and Statti, G (2024) 'Effects of Arnica montana Phytotherapeutic and Homeopathic Formulations on Traumatic Injuries and Inflammatory Conditions: A Systematic Review', Plants (Basel), 13(21), pp. 3112. doi:10.3390/plants13213112 Meta-analysis / review
https://doi.org/10.3390/plants13213112 - Schmidt, T.J (2023) 'Arnica montana L.: Doesn't Origin Matter?', Plants (Basel), 12(20), pp. 3532. doi:10.3390/plants12203532 Traditional / reference
https://doi.org/10.3390/plants12203532 - Dragos, D., Gilca, M., Gaman, L., Vlad, A., Iosif, L. et al (2017) 'Phytomedicine in Joint Disorders', Nutrients, 9(1), pp. 70. doi:10.3390/nu9010070 Traditional / reference
https://doi.org/10.3390/nu9010070 - Kriplani, P., Guarve, K. and Baghael, U.S (2017) 'Arnica montana L. - a plant of healing: review', Journal of Pharmacy and Pharmacology, pp. 12724. doi:10.1111/jphp.12724 Traditional / reference
https://doi.org/10.1111/jphp.12724 - Iannitti, T., Morales-Medina, J.C., Bellavite, P., Rottigni, V. and Palmieri, B (2016) 'Effectiveness and safety of Arnica montana in post-surgical setting, pain and inflammation', American Journal of Therapeutics, 23(1), pp. e184-e197. doi:10.1097/MJT.0000000000000036 Meta-analysis / review
https://doi.org/10.1097/MJT.0000000000000036 - Verre, J., Boisson, M., Paumier, A., Tribolo, S. and Boujedaini, N (2023) 'Anti-inflammatory effects of Arnica montana (mother tincture and homeopathic dilutions) in various cell models', Journal of Ethnopharmacology, 318(Pt B), pp. 117064. doi:10.1016/j.jep.2023.117064 Preclinical
https://doi.org/10.1016/j.jep.2023.117064 - Rohrl, J., Pique-Borras, M., Jaklin, M., Werner, M., Werz, O., Josef, H., Holz, H., Ammendola, A. and Kunstle, G (2023) 'Anti-inflammatory activities of Arnica montana planta tota versus flower extracts: analytical, in vitro and in vivo mouse paw oedema model studies', Plants, 12(6), pp. 1348. doi:10.3390/plants12061348 Preclinical
https://doi.org/10.3390/plants12061348 - da Silva Prade, J., Balsamo, E.C., Machado, F.R., Poetini, M.R., Bortolotto, V.C., Araujo, S.M., Londero, L., Boeira, S.P., Sehn, C.P., de Gomes, M.G., Prigol, M. and Cattelan Souza, L (2020) 'Anti-inflammatory effect of Arnica montana in a UVB radiation-induced skin-burn model in mice', Cutaneous and Ocular Toxicology, 39(2), pp. 126-133. doi:10.1080/15569527.2020.1743998 Preclinical
https://doi.org/10.1080/15569527.2020.1743998 - Zacarias, C.A., de Mendonca Florenziano, R.F., de Andrade, T.A.M., de Aro, A.A., do Amaral, M.E.C., Dos Santos, G.M.T. and Esquisatto, M.A.M (2023) 'Arnica montana L. associated with microcurrent accelerates the dermis reorganisation of skin lesions', International Journal of Experimental Pathology, 104(2), pp. 81-95. doi:10.1111/iep.12469 Preclinical
https://doi.org/10.1111/iep.12469 - Chaiet, S.R. and Marcus, B.C (2016) 'Perioperative Arnica montana for reduction of ecchymosis in rhinoplasty surgery', Annals of Plastic Surgery, 76(5), pp. 477-482. doi:10.1097/SAP.0000000000000312 Randomized trial
https://doi.org/10.1097/SAP.0000000000000312 - Zitek, T., Postruznik, V., Knez, Z., Golle, A., Daris, B. and Knez Marevci, M (2022) 'Arnica montana L. supercritical extraction optimization for antibiotic and anticancer activity', Frontiers in Bioengineering and Biotechnology, 10, pp. 897185. doi:10.3389/fbioe.2022.897185 Preclinical
https://doi.org/10.3389/fbioe.2022.897185 - Sutovska, M., Capek, P., Kocmalova, M., Pawlaczyk, I., Zaczynska, E., Czarny, A., Uhliarikova, I., Gancarz, R. and Franova, S (2014) 'Characterization and pharmacodynamic properties of Arnica montana complex', International Journal of Biological Macromolecules, 69, pp. 214-221. doi:10.1016/j.ijbiomac.2014.05.051 Preclinical
https://doi.org/10.1016/j.ijbiomac.2014.05.051 - Merfort, I. and Wendisch, D (1987) 'Flavonoid glycosides from Arnica montana and Arnica chamissonis', Planta Medica, 53(5), pp. 434-437. doi:10.1055/s-2006-962766 Preclinical
https://doi.org/10.1055/s-2006-962766 - European Medicines Agency (HMPC) (2012) 'Community herbal monograph on Arnica montana L., flos'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arnica-montana-l-flos_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arnica-montana-l-flos_en.pdf - Gaertner, K., Baumgartner, S. and Walach, H (2021) 'Is Homeopathic Arnica Effective for Postoperative Recovery? A Meta-analysis of Placebo-Controlled and Active Comparator Trials', Frontiers in Surgery. doi:10.3389/fsurg.2021.680930 Meta-analysis / review
https://doi.org/10.3389/fsurg.2021.680930 - Kriplani, P. and Guarve, K (2020) 'Recent Patents on Anti-Cancer Potential of Helenalin', Recent Patents on Anti-Cancer Drug Discovery, 15(2), pp. 132-142. doi:10.2174/1574892815666200702142601 Preclinical
https://doi.org/10.2174/1574892815666200702142601 - Drogosz, J. and Janecka, A (2019) 'Helenalin - A Sesquiterpene Lactone with Multidirectional Activity', Current Drug Targets, 20(4), pp. 444-452. doi:10.2174/1389450119666181012125230 Preclinical
https://doi.org/10.2174/1389450119666181012125230 - National Capital Poison Center (Poison Control) (n.d.) 'Caution when using Arnica products'. Available at: https://www.poison.org/articles/caution-when-using-arnica-products-193 Traditional / reference
https://www.poison.org/articles/caution-when-using-arnica-products-193
- Camilleri, E., Blundell, R., Baral, B., Karpinski, T.M. et al (2024) 'A brief overview of the medicinal and nutraceutical importance of Inonotus obliquus (chaga) mushrooms', Heliyon, 10(15), pp. e35638. doi:10.1016/j.heliyon.2024.e35638 Traditional / reference
https://doi.org/10.1016/j.heliyon.2024.e35638 - Lu, Y., Jia, Y., Xue, Z., Li, N. et al (2021) 'Recent Developments in Inonotus obliquus (Chaga mushroom) Polysaccharides: Isolation, Structural Characteristics, Biological Activities and Application', Polymers (Basel), 13(9), pp. 1441. doi:10.3390/polym13091441 Traditional / reference
https://doi.org/10.3390/polym13091441 - Kobus, Z., Krzywicka, M., Blicharz-Kania, A., Bosacka, A. et al (2024) 'Impact of Incorporating Dried Chaga Mushroom (Inonotus obliquus) into Gluten-Free Bread on Its Antioxidant and Sensory Characteristics', Molecules, 29(16), pp. 3801. doi:10.3390/molecules29163801 Preclinical
https://doi.org/10.3390/molecules29163801 - Szychowski, K.A., Skora, B., Pomianek, T. and Gminski, J (2020) 'Inonotus obliquus - from folk medicine to clinical use', Journal of Traditional and Complementary Medicine, 11(4), pp. 293-302. doi:10.1016/j.jtcme.2020.08.003 Meta-analysis / review
https://doi.org/10.1016/j.jtcme.2020.08.003 - Javed, S., Mitchell, K., Sidsworth, D., Sellers, S.L., Reutens-Hernandez, J., Massicotte, H.B., Egger, K.N., Lee, C.H. and Payne, G.W (2019) 'Inonotus obliquus attenuates histamine-induced microvascular inflammation', PLoS One, 14(8), pp. e0220776. doi:10.1371/journal.pone.0220776 Preclinical
https://doi.org/10.1371/journal.pone.0220776 - Zou, C., Hou, Z., Bai, M., Guo, R., Lin, B., Wang, X., Huang, X. and Song, S (2020) 'Highly modified steroids from Inonotus obliquus', Organic & Biomolecular Chemistry, 18(20), pp. 3908-3916. doi:10.1039/d0ob00474j Preclinical
https://doi.org/10.1039/d0ob00474j - Zhong, X.H., Ren, K., Lu, S.J., Yang, S.Y. and Sun, D.Z (2009) 'Progress of research on Inonotus obliquus', Chinese Journal of Integrative Medicine, 15(2), pp. 156-160. doi:10.1007/s11655-009-0156-2 Meta-analysis / review
https://doi.org/10.1007/s11655-009-0156-2 - Burmasova, M.A., Utebaeva, A.A., Sysoeva, E.V. and Sysoeva, M.A (2019) 'Melanins of Inonotus obliquus: bifidogenic and antioxidant properties', Biomolecules, 9(6), pp. 248. doi:10.3390/biom9060248 Preclinical
https://doi.org/10.3390/biom9060248 - Sun, Y., Deng, X., Li, Z., Dong, Y., Jiang, W., Ma, Y., Zhou, W., Zhu, T., Wang, G., Liu, S. and Hu, B (2022) 'Polysaccharide derived from Inonotus obliquus inhibits lipopolysaccharide-induced acute endometritis in mice', American Journal of Translational Research, 14(11), pp. 8332-8342. Preclinical
https://scholar.google.com/scholar?q=Polysaccharide%20derived%20from%20Inonotus%20obliquus%20inhibits%20lipopolysaccharide-induced%20acute%20endometritis%20in%20mice - Ishfaq, P.M., Mishra, S., Mishra, A., Ahmad, Z., Gayen, S., Jain, S.K., Tripathi, S. and Mishra, S.K (2022) 'Inonotus obliquus aqueous extract prevents histopathological alterations in liver induced by environmental toxicant Microcystin', Current Research in Pharmacology and Drug Discovery, 3, pp. 100118. doi:10.1016/j.crphar.2022.100118 Preclinical
https://doi.org/10.1016/j.crphar.2022.100118 - Peng, A., Liu, S., Fang, L., Zhu, Z., Zhou, Y., Yue, S., Ma, Z., Liu, X., Xue, S., Qiu, Y. and Qi, R (2022) 'Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR/SHP/SREBP-1c axis', European Journal of Pharmacology, 921, pp. 174841. doi:10.1016/j.ejphar.2022.174841 Preclinical
https://doi.org/10.1016/j.ejphar.2022.174841 - Zhang, Y., Liu, Q., Sun, Y. and Jiang, J (2023) 'Inonotus obliquus sclerotia epidermis were different from internal tissues in compound composition, antioxidant activity, and associated fungi', FEMS Microbiology Letters, 370, pp. fnad126. doi:10.1093/femsle/fnad126 Preclinical
https://doi.org/10.1093/femsle/fnad126 - Yu, S., Lai, Z., Xue, H., Zhu, J., Yue, G., Wang, J. and Jin, L.H (2024) 'Inonotus obliquus aqueous extract inhibits intestinal inflammation and insulin metabolism defects in Drosophila', Toxicology Mechanisms and Methods, 34(9), pp. 970-984. doi:10.1080/15376516.2024.2368795 Preclinical
https://doi.org/10.1080/15376516.2024.2368795 - Wold, C.W. and Christopoulos, P. and Arias, M. and Dzovor, D.E. and Øynebråten, I. and Corthay, A. and Inngjerdingen, K.T (2024) 'Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity', Communications Biology. doi:10.1038/s42003-024-05853-y Preclinical
https://doi.org/10.1038/s42003-024-05853-y - Li, J. and Qu, C. and Li, F. and Chen, Y. and Zheng, J. and Xiao, Y. and Jin, Q. and Jin, G. and Huang, X. and Jin, D (2021) 'Inonotus obliquus Polysaccharide Ameliorates Azoxymethane/Dextran Sulfate Sodium-Induced Colitis-Associated Cancer in Mice via Activation of the NLRP3 Inflammasome', Frontiers in Pharmacology. doi:10.3389/fphar.2020.621835 Preclinical
https://doi.org/10.3389/fphar.2020.621835 - Wold, C.W. and Gerwick, W.H. and Wangensteen, H. and Inngjerdingen, K.T (2020) 'Bioactive triterpenoids and water-soluble melanin from Inonotus obliquus (Chaga) with immunomodulatory activity', Journal of Functional Foods. doi:10.1016/j.jff.2020.104025 Preclinical
https://doi.org/10.1016/j.jff.2020.104025 - Kim, J. and Yang, S. and Hwang, A.Y. and Cho, H. and Hwang, K.T (2020) 'Composition of Triterpenoids in Inonotus obliquus and Their Anti-Proliferative Activity on Cancer Cell Lines', Molecules. doi:10.3390/molecules25184066 Preclinical
https://doi.org/10.3390/molecules25184066 - Duru, K.C. and Kovaleva, E.G. and Данилова, И.Г. and Bijl, P.V.D (2019) 'The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies', Phytotherapy Research. doi:10.1002/ptr.6384 Preclinical
https://doi.org/10.1002/ptr.6384 - Hu, Y. and Teng, C. and Yu, S. and Wang, X. and Liang, J. and Bai, X. and Dong, L. and Song, T. and Yu, M. and Qu, J (2017) 'Inonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice', AMB Express. doi:10.1186/s13568-017-0341-1 Preclinical
https://doi.org/10.1186/s13568-017-0341-1 - Chou, Y. and Kan, W. and Chang, C. and Peng, Y. and Wang, H. and Yu, W. and Cheng, Y. and Jhang, Y. and Liu, H. and Chuu, J (2016) 'Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice', International Journal of Molecular Sciences. doi:10.3390/ijms17091535 Preclinical
https://doi.org/10.3390/ijms17091535 - Arata, S. and Watanabe, J. and Maeda, M. and Yamamoto, M. and Matsuhashi, H. and Mochizuki, M. and Kagami, N. and Honda, K. and Inagaki, M (2016) 'Continuous intake of the Chaga mushroom (Inonotus obliquus) aqueous extract suppresses cancer progression and maintains body temperature in mice', Heliyon. doi:10.1016/j.heliyon.2016.e00111 Preclinical
https://doi.org/10.1016/j.heliyon.2016.e00111 - Lee, K.R. and Lee, J.S. and Kim, Y.R. and Song, I.G. and Hong, E.K (2014) 'Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-κB signaling pathway', Oncology Reports. doi:10.3892/or.2014.3103 Preclinical
https://doi.org/10.3892/or.2014.3103 - Song, F. and Liu, Y. and Kong, X. and Chang, W. and Song, G (2013) 'Progress on Understanding the Anticancer Mechanisms of Medicinal Mushroom: Inonotus Obliquus', Asian Pacific Journal of Cancer Prevention. doi:10.7314/apjcp.2013.14.3.1571 Preclinical
https://doi.org/10.7314/apjcp.2013.14.3.1571 - Gunjima, K. and Tomiyama, R. and Takakura, K. and Yamada, T. and Hashida, K. and Nakamura, Y. and Konishi, T. and Matsugo, S. and Hori, O (2013) '3,4‐Dihydroxybenzalacetone Protects Against Parkinson's Disease‐Related Neurotoxin 6‐OHDA Through Akt/Nrf2/Glutathione Pathway', Journal of Cellular Biochemistry. doi:10.1002/jcb.24643 Preclinical
https://doi.org/10.1002/jcb.24643 - Geng, Y. and Lu, Z. and Huang, W. and Xu, H. and Shi, J. and Xu, Z (2013) 'Bioassay-Guided Isolation of DPP-4 Inhibitory Fractions from Extracts of Submerged Cultured of Inonotus obliquus', Molecules. doi:10.3390/molecules18011150 Preclinical
https://doi.org/10.3390/molecules18011150 - Zhang, L. and Fan, C. and Liu, S. and Zang, Z. and Jiao, L. and Zhang, L (2011) 'Chemical composition and antitumor activity of polysaccharide from Inonotus obliquus', Journal of Medicinal Plants Research. doi:10.5897/jmpr.9000346 Preclinical
https://doi.org/10.5897/jmpr.9000346 - Choi, S. and Hur, S.J. and An, C.S. and Jeon, Y.H. and Jeoung, Y.J. and Bak, J.P. and Lim, B.O (2010) 'Anti-Inflammatory Effects ofInonotus obliquusin Colitis Induced by Dextran Sodium Sulfate', Journal of Biomedicine and Biotechnology. doi:10.1155/2010/943516 Preclinical
https://doi.org/10.1155/2010/943516 - Youn, M. and Kim, J. and Park, S. and Kim, Y. and Kim, S. and Lee, J.S. and Chai, K.Y. and Kim, H. and Cui, M. and So, H.S. and Kim, K. and Park, R (2008) 'Chaga mushroom (Inonotus obliquus ) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells', World Journal of Gastroenterology. doi:10.3748/wjg.14.511 Preclinical
https://doi.org/10.3748/wjg.14.511 - Nakajima, Y. and Sato, Y. and Konishi, T (2007) 'Antioxidant Small Phenolic Ingredients in Inonotus obliquus (persoon) Pilat (Chaga)', Chemical and Pharmaceutical Bulletin. doi:10.1248/cpb.55.1222 Preclinical
https://doi.org/10.1248/cpb.55.1222 - Kim, H. and Yoon, D. and Kim, C. and Shrestha, B. and Chang, W. and Lim, S. and Lee, W. and Han, S. and Lee, J. and Lim, M. and Kim, G. and Choi, S. and Song, W.O. and Sung, J. and Hwang, K (2007) 'Ethanol Extract of Inonotus obliquus Inhibits Lipopolysaccharide-Induced Inflammation in RAW 264.7 Macrophage Cells', Journal of Medicinal Food. doi:10.1089/jmf.2006.156 Preclinical
https://doi.org/10.1089/jmf.2006.156 - Mizuno, T. and Zhuang, C. and Abe, K. and Okamoto, H. and Kiho, T. and Ukai, S. and Leclerc, S. and Meijer, L (1999) 'Antitumor and Hypoglycemic Activities of Polysaccharides from the Sclerotia and Mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae)', International journal of medicinal mushrooms. doi:10.1615/intjmedmushr.v1.i4.20 Preclinical
https://doi.org/10.1615/intjmedmushr.v1.i4.20 - Su, L. and Xin, C. and Yang, J. and Dong, L. and Mei, H. and Dai, X. and Wang, Q (2022) 'A polysaccharide from Inonotus obliquus ameliorates intestinal barrier dysfunction in mice with type 2 diabetes mellitus', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2022.06.071 Preclinical
https://doi.org/10.1016/j.ijbiomac.2022.06.071 - Yang, M. and Hu, D. and Cui, Z. and Li, H. and Man, C. and Jiang, Y (2021) 'Lipid-Lowering Effects of Inonotus obliquus Polysaccharide In Vivo and In Vitro', Foods. doi:10.3390/foods10123085 Preclinical
https://doi.org/10.3390/foods10123085 - Wang, J. and Hu, W. and Li, L. and Huang, X. and Liu, Y. and Wang, D. and Teng, L (2017) 'Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes', PLoS ONE. doi:10.1371/journal.pone.0180476 Preclinical
https://doi.org/10.1371/journal.pone.0180476 - Giridharan, V.V. and Thandavarayan, R.A. and Konishi, T (2011) 'Amelioration of scopolamine induced cognitive dysfunction and oxidative stress by Inonotus obliquus– a medicinal mushroom', Food & Function. doi:10.1039/c1fo10037h Preclinical
https://doi.org/10.1039/c1fo10037h - Lee, J. and Hyun, C (2014) 'Insulin‐Sensitizing and Beneficial Lipid‐Metabolic Effects of the Water‐Soluble Melanin Complex Extracted from Inonotus obliquus', Phytotherapy Research. doi:10.1002/ptr.5131 Preclinical
https://doi.org/10.1002/ptr.5131 - Kim, Y (2005) 'Immunomodulatory Activity of the Water Extract from Medicinal MushroomInonotus obliquus', Mycobiology. doi:10.4489/myco.2005.33.3.158 Preclinical
https://doi.org/10.4489/myco.2005.33.3.158 - Géry, A., Dubreule, C., André, V., Rioult, J.P., Bouchart, V., Heutte, N., Eldin de Pécoulas, P., Krivomaz, T. and Garon, D (2018) 'Chaga (Inonotus obliquus), a future potential medicinal fungus in oncology? A chemical study and a comparison of the cytotoxicity against human lung adenocarcinoma cells (A549) and human bronchial epithelial cells (BEAS-2B)', 17(3), pp. 832--843. doi:10.1177/1534735418757912 Traditional / reference
https://doi.org/10.1177/1534735418757912 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Shashkina, M.Ya., Shashkin, P.N. and Sergeev, A.V (2006) 'Chemical and medicobiological properties of chaga', 40(10), pp. 560--568. Traditional / reference
https://scholar.google.com/scholar?q=Chemical%20and%20medicobiological%20properties%20of%20chaga - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.